These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2137768)

  • 1. T-lymphocytes in leprosy lesions.
    Mehra V; Modlin RL
    Curr Top Microbiol Immunol; 1990; 155():97-109. PubMed ID: 2137768
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on T-cell sub-populations in type II reactions.
    Kalyanasundaram K; Elangeswaran N; Bhatia VN; Thiagarajan M; Sirumban P
    Indian J Lepr; 1989 Jan; 61(1):79-83. PubMed ID: 2522975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 4. Restoration of defective cytokine activity within lepromatous leprosy lesions.
    Volc-Platzer B; Kremsner P; Stemberger H; Wiedermann G
    Zentralbl Bakteriol; 1990 Apr; 272(4):458-66. PubMed ID: 1972881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte subsets in leprosy.
    Gonzalez-Amaro R; Moncada B; Loredeo CE; de Lourdes Baranda M
    Int J Dermatol; 1983 Jun; 22(5):305-6. PubMed ID: 6223893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathology of leprosy skin lesions.
    Rea TH; Modlin RL
    Semin Dermatol; 1991 Sep; 10(3):188-93. PubMed ID: 1931567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte subsets in the skin lesions of patients with leprosy.
    Modlin RL; Hofman FM; Taylor CR; Rea TH
    J Am Acad Dermatol; 1983 Feb; 8(2):182-9. PubMed ID: 6219136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunologic pathways in the pathogenesis of leprosy: role for Th22 cytokines in the polar forms of the disease.
    de Lima Silveira E; de Sousa JR; de Sousa Aarão TL; Fuzii HT; Dias Junior LB; Carneiro FR; Quaresma JA
    J Am Acad Dermatol; 2015 Apr; 72(4):729-30. PubMed ID: 25773413
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic control of immunopathology induced by Mycobacterium leprae.
    de Vries RR
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of the soluble E-receptor of human T lymphocytes by rocket electrophoresis in the serum of patients with lepromatous and tuberculoid leprosy.
    Longo IM; Moura NC; Opromolla D; Mendes NF
    Medicina (B Aires); 1991; 51(2):133-6. PubMed ID: 1820499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
    N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for IL-12 receptor expression and signal transduction in host defense in leprosy.
    Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL
    J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulation: learning from leprosy.
    Modlin RL; Bloom BR
    Hosp Pract (Off Ed); 1993 Nov; 28(11):71-4, 77-80, 83-4. PubMed ID: 8227249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte clones from leprosy skin lesions.
    Modlin RL; Gersuk GM; Nelson EE; Pattengale PK; Gunter JR; Chen L; Cooper CL; Bloom BR; Rea TH
    Lepr Rev; 1986 Dec; 57 Suppl 2():143-7. PubMed ID: 2952855
    [No Abstract]   [Full Text] [Related]  

  • 17. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.
    Cooper CL; Mueller C; Sinchaisri TA; Pirmez C; Chan J; Kaplan G; Young SM; Weissman IL; Bloom BR; Rea TH; Modlin RL
    J Exp Med; 1989 May; 169(5):1565-81. PubMed ID: 2523952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.